Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
about
Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomasMicroRNAs in NF-kappaB signalingHistone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemiaCap-Independent Translation in Hematological MalignanciesmicroRNA regulation of peritoneal cavity homeostasis in peritoneal dialysisThe cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)Epigenomics of leukemia: from mechanisms to therapeutic applicationsMicroRNAs: new regulators of Toll-like receptor signalling pathwaysEpigenetics advancing personalized nanomedicine in cancer therapyMicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tuneThe DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer CellsThe prognostic and functional role of microRNAs in acute myeloid leukemiaTherapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAsThe Role of the Ubiquitously Expressed Transcription Factor Sp1 in Tissue-specific Transcriptional Regulation and in DiseaseThe microRNA-29 family in cartilage homeostasis and osteoarthritisMicroRNA-29a inhibited epididymal epithelial cell proliferation by targeting nuclear autoantigenic sperm protein (NASP)MicroRNA regulation of innate immune responses in epithelial cellsThymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells.Cell-specific expression of aquaporin-5 (Aqp5) in alveolar epithelium is directed by GATA6/Sp1 via histone acetylationThe large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesis.Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction.ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer.miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB.Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis.Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia.The role of microRNAs in acute myeloid leukemia.Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases.Pathogenic microRNA's in myeloid malignancies.Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice.MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives.Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertensionHow microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation.Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool.Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29.Function and mechanism of tumor suppressor gene LRRC4/NGL-2.NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival.MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib.MicroRNA-26a-5p and microRNA-23b-3p up-regulate peroxiredoxin III in acute myeloid leukemia.
P2860
Q24301269-BCF27DBD-2616-4E9B-935F-C9980D4A02C1Q24630097-3740CE1D-826A-4CD8-AA1C-CECB1F0F014DQ24633394-C2801D31-DE4B-4C83-A1F1-A42F9F11BB08Q26770568-A6F66083-6AE7-4AD6-A6EF-4A6E7C3C460AQ26779972-CC12CE4E-E34C-4860-B6FA-BC0DBD0DB764Q26799398-9B0BEEA1-8E08-4707-9663-69BE660B7128Q26823403-D7F2D510-565A-42AF-AA6E-58ED459BC138Q27010055-DCA47BF8-BCFB-4215-994D-722974D4EFFEQ27010637-3E3092C2-74BE-4579-9F32-A787938F5051Q27013740-160938C3-AF95-48FD-B70B-11988409A6AEQ27313466-E28DBFB5-3C42-4164-A811-E00A0B467255Q27693865-611A6662-CFD9-47A8-8DB9-415243C3ADC8Q28071427-683BF101-EAE3-4194-8CD2-1AB1350B7F39Q28076855-2F8DFC0B-5676-4159-8381-1CE917049DC2Q28115325-FCCFC144-4316-460B-BE1D-79E9500E52AFQ28566117-0BB20026-7F3B-4A00-9F01-6FCF7AF8360CQ33577518-27361F0B-D236-415D-9D20-34F0B795B785Q33798412-AB998BB8-A507-43F7-93DD-0C291419CD2BQ33799346-F53253CE-4B50-4964-8923-C0EBA3CBDA47Q33842055-AB9BE262-03C7-48AB-A7EC-BF0EBEB43120Q33859252-30FC85E3-C268-45DE-898D-30AC29C2AB41Q33974555-C66A2F1D-D96F-4113-9515-3AFD131ECFAEQ34168267-5581B290-1B41-4B61-92A3-997BFF3157D4Q34180373-09D7B9EA-B7C2-400A-A078-72917498AF4AQ34193684-88BDB3CA-2295-45B7-A76E-8157398DC4B2Q34221688-883BDE84-A831-4A38-AC40-962B268F2F6EQ34309928-BE90E943-D3AE-473E-90D1-BA02843C5D36Q34389746-0A081BD9-8633-4D32-B620-28E53B111402Q34458438-915CE5AD-4C61-4D23-AFC5-BFC83C748B06Q34541057-E75E866A-5036-4AAD-AFDC-287537708A9CQ34542559-D6C8269F-D8C4-43A6-96E7-48EF92E8647BQ34599354-FE7AFC7A-D3EA-48F2-BC07-7881253C5941Q34875675-255E9239-F2D5-41C1-9A7A-8B0F8502BA56Q34979339-300F48E3-D1DD-4CD2-9681-2E802873B26CQ35029942-388D4D57-D7E0-4794-9865-C66800F18871Q35065212-C1EF620D-0D78-46A2-8091-70D245F087EDQ35147345-D59BADCD-BC44-4C16-AA75-B1AEFCAA6FB5Q35167587-79F38664-E7A3-4863-9272-CE661EFD02FFQ35178969-365D655E-7BFB-4239-BA67-D3BD78380C56Q35190147-C6641AD4-B7FA-4CD4-AA11-8C1C6D4B96E1
P2860
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
@ast
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
@en
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
@nl
type
label
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
@ast
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
@en
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
@nl
prefLabel
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
@ast
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
@en
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
@nl
P2093
P2860
P50
P1433
P1476
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
@en
P2093
Anjali Mishra
Anna M Eiring
Chenglong Li
Christopher J Hickey
Danilo Perrotti
Heiko Becker
Jianhua Yu
Jiuxia Pang
Kenneth K Chan
Lai-Chu Wu
P2860
P304
P356
10.1016/J.CCR.2010.03.008
P577
2010-04-01T00:00:00Z